Japan's health ministry said on Friday it agreed to buy 1.4 million doses of Daiichi Sankyo's updated COVID-19 vaccine. The purchase is contingent on approval of the shot formulated for the XBB.1.5 ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Man walks past a sign of Daiichi Sankyo Co., Ltd. at the company's head office in Tokyo TOKYO (Reuters) - Japan's ...

Daiichi Sankyo has announced approval from the Japan Ministry of Health, Labour and Welfare for EZHARMIA (valemetostat tosilate) to treat relapsed or refractory (r/r) peripheral T-cell lymphoma (PTCL) ...

TOKYO, March 13 (Reuters) - Japan's Sanko Steamship sought to reassure its clients on Tuesday that day-to-day operations for nearly 200 vessels were running as normal, four days after alerting ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration shows vials labelled "VACCINE Coronavirus COVID-19" and a syringe in front of a displayed Japanese flag TOKYO ...

Daiichi Sankyo said today it will close its Japanese research subsidiary Asubio Pharma in the pharma giant’s second shutdown of an overseas R&D operation in as many months. Daiichi Sankyo said it will ...

Japan's Daiichi Sankyo, which has been reorganizing its API production as part of a larger cost-cutting initiative, says it will close a plant in Japan where it has 150 employees. In a brief release, ...